P Honerjäger

681 total citations
27 papers, 545 citations indexed

About

P Honerjäger is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, P Honerjäger has authored 27 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in P Honerjäger's work include Ion channel regulation and function (10 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Phosphodiesterase function and regulation (6 papers). P Honerjäger is often cited by papers focused on Ion channel regulation and function (10 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Phosphodiesterase function and regulation (6 papers). P Honerjäger collaborates with scholars based in Germany, United Kingdom and United States. P Honerjäger's co-authors include M. Reiter, Monika Schäfer‐Korting, P. F. Baker, M Dugas, Xuemei Zong, Hermann Nawrath, Xin Zong, Peter R. Freund, J C Rüegg and Peter F. Baker and has published in prestigious journals such as Nature, Circulation Research and The Journal of Physiology.

In The Last Decade

P Honerjäger

26 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Honerjäger Germany 13 348 281 158 64 36 27 545
R Salzmann Japan 12 312 0.9× 195 0.7× 190 1.2× 70 1.1× 26 0.7× 31 644
A J Pappano United States 13 399 1.1× 301 1.1× 194 1.2× 46 0.7× 30 0.8× 23 527
Akihiko Sunami Japan 14 572 1.6× 373 1.3× 259 1.6× 39 0.6× 11 0.3× 27 713
S S Sheu United States 9 587 1.7× 485 1.7× 311 2.0× 31 0.5× 84 2.3× 10 788
V.C. Swamy United States 12 375 1.1× 136 0.5× 178 1.1× 172 2.7× 20 0.6× 26 594
U. Borchard Germany 15 349 1.0× 318 1.1× 160 1.0× 84 1.3× 80 2.2× 56 723
Donald D. Doyle United States 14 406 1.2× 204 0.7× 125 0.8× 51 0.8× 9 0.3× 20 556
N Taira Japan 8 254 0.7× 310 1.1× 68 0.4× 91 1.4× 37 1.0× 10 461
Yoshiaki Nakamaru Japan 8 229 0.7× 143 0.5× 61 0.4× 33 0.5× 29 0.8× 17 432
M Endoh Japan 12 448 1.3× 377 1.3× 169 1.1× 162 2.5× 47 1.3× 16 625

Countries citing papers authored by P Honerjäger

Since Specialization
Citations

This map shows the geographic impact of P Honerjäger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Honerjäger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Honerjäger more than expected).

Fields of papers citing papers by P Honerjäger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Honerjäger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Honerjäger. The network helps show where P Honerjäger may publish in the future.

Co-authorship network of co-authors of P Honerjäger

This figure shows the co-authorship network connecting the top 25 collaborators of P Honerjäger. A scholar is included among the top collaborators of P Honerjäger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Honerjäger. P Honerjäger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Honerjäger, P, et al.. (1993). [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].. PubMed. 48(9). 425–9. 1 indexed citations
2.
Zong, Xuemei, M Dugas, & P Honerjäger. (1992). Relation between veratridine reaction dynamics and macroscopic Na current in single cardiac cells.. The Journal of General Physiology. 99(5). 683–697. 21 indexed citations
3.
Honerjäger, P, M Dugas, & Xin Zong. (1992). Mutually exclusive action of cationic veratridine and cevadine at an intracellular site of the cardiac sodium channel.. The Journal of General Physiology. 99(5). 699–720. 13 indexed citations
4.
Honerjäger, P & Hermann Nawrath. (1992). Pharmacology of bipyridine phosphodiesterase III inhibitors.. PubMed. 5. 7–14. 12 indexed citations
5.
Honerjäger, P, et al.. (1992). Pharmacodynamics of Nilvadipine, a New Dihydropyridine- Type Calcium Antagonist. Journal of Cardiovascular Pharmacology. 20. 15–21. 2 indexed citations
6.
Honerjäger, P, et al.. (1992). [New anti-arrhythmia agents].. PubMed. 81 Suppl 4. 133–7. 1 indexed citations
7.
Honerjäger, P. (1991). Pharmacology of bipyridine phosphodiesterase III inhibitors. American Heart Journal. 121(6). 1939–1944. 63 indexed citations
8.
Dugas, M, et al.. (1990). Interaction between DPI 201-106 enantiomers at the cardiac sodium channel.. Molecular Pharmacology. 37(1). 17–24. 25 indexed citations
9.
Dugas, M, et al.. (1990). Sodium channel comodification with full activator reveals veratridine reaction dynamics.. Molecular Pharmacology. 37(2). 144–148. 24 indexed citations
10.
Honerjäger, P. (1990). Pharmacology of positive inotropic phosphodiesterase III inhibitors. Pharmacological Research. 22. 245–245. 2 indexed citations
11.
Honerjäger, P, et al.. (1990). Microscopic reaction dynamics of five ceveratrum alkaloids at the cardiac sodium channel. European Journal of Pharmacology. 183(2). 271–272. 1 indexed citations
12.
Dugas, M, et al.. (1989). Tetrodotoxin block of single germitrine‐activated sodium channels in cultured rat cardiac cells.. The Journal of Physiology. 411(1). 611–626. 5 indexed citations
13.
Honerjäger, P. (1989). Pharmacology of positive inotropic phosphodiesterase III inhibitors. European Heart Journal. 10(suppl C). 25–31. 21 indexed citations
14.
Honerjäger, P, et al.. (1989). Imidazopyridines. Journal of Cardiovascular Pharmacology. 13(5). 673–681. 10 indexed citations
15.
Müller‐Beckmann, B., et al.. (1988). In Vitro Investigations on a New Positive Inotropic and Vasodilating Agent (BM 14.478) That Increases Myocardial Cyclic AMP Content and Myofibrillar Calcium Sensitivity. Journal of Cardiovascular Pharmacology. 11(1). 8–16. 17 indexed citations
16.
Scholtysik, G., et al.. (1985). Positive Inotropic and Electrophysiological Effects of APP 201-533 Can Be Explained by an Increase of Cardiac Cyclic AMP. Journal of Cardiovascular Pharmacology. 7(3). 597–603. 5 indexed citations
17.
Honerjäger, P. (1982). Cardioactive substances that prolong the open state of sodium channels. Reviews of physiology, biochemistry and pharmacology. 92. 1–74. 106 indexed citations
18.
Honerjäger, P, Melchior Reiter, & Peter F. Baker. (1981). Effect of the Cardioactive Drug AR-L 57 on Free Intracellular Calcium and Ouabain-Insensitive Ion Fluxes in the Squid Giant Axon. Molecular Pharmacology. 19(1). 68–77. 2 indexed citations
19.
Honerjäger, P, Monika Schäfer‐Korting, & M. Reiter. (1981). Involvement of cyclic AMP in the direct inotropic action of amrinone. Naunyn-Schmiedeberg s Archives of Pharmacology. 318(2). 112–120. 113 indexed citations
20.
Honerjäger, P, Melchior Reiter, & Peter F. Baker. (1980). Inhibition of the Sodium Pump in Squid Axons by the Cardioactive Drug AR-L 57. Molecular Pharmacology. 17(3). 350–355. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026